Return to homepagePandemic Pact

Transmisión de SARS-CoV2 por el aire: detección en hospitales y tecnologías innovadoras

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00144

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Antonio Alcamí Pertejo

  • Research Location

    Spain

  • Lead Research Institution

    AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, M.P.

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

There are currently no effective methodologies to detect viruses in the air. Our group has recently optimized filter-based methods capable of retaining the entire airborne virus community. SARS-CoV2 is stable in the air for at least 3 hours and is very effective in transmission, but its airborne spread has not been studied. We propose to use this methodology to detect SARS-CoV2 in hospitals and carry out a longitudinal study of the prevalence of the virus in hospital spaces. In parallel, we will develop nanoparticles as simple colorimetric detection methods, applicable to hospitals, to quickly monitor the presence of viruses captured in the air. We will develop laser-induced fluorescence (LIF) sensors as a method of direct detection of SARS-CoV2 particles and other viruses in the air, without the need to process the samples